Table 6a.
Parietal lobe phospholipid mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD | Patient | Mean (control) | SD | |
|
|
||||||
| EtnGpl | 18209 | 16292 | 4543 | 41.7% | 39.5% | 0.4%* |
| PtdIns | 1093 | 1209 | 245 | 2.5% | 3.0% | 0.3% |
| PtdSer | 5404 | 5430 | 2205 | 12.4% | 12.8% | 2.2% |
| ChoGpl | 14766 | 14015 | 2866 | 33.8% | 34.6% | 3.4% |
| CerPCho | 4214 | 4297 | 1624 | 9.6% | 10.2% | 1.4% |
| Total | 43685 | 41243 | 11383 | |||
| n = 1 | n = 3 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
*
indicates significance between patient and control group, 2 SD from control mean.